Article Details
Retrieved on: 2024-04-03 20:15:10
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
LOS ALTOS, Calif., April 03, 2024--Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO) today announced the initiation of its Phase 2 double-blind, ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here